ULK2 (Gene)

Synonyms:ATG1B, ENTREZ:9706, HGNC:13480, MIM:608650, NM_001142610, NM_014683, NP_001136082, NP_055498, ULK2, Unc51.2, XM_011524087, XM_017025424, XM_017025425, XM_017025426, XM_017025427, XM_017025428, XP_011522389, XP_016880913, XP_016880914, XP_016880915, XP_016880916, XP_016880917, XR_001752700, XR_001752701, unc-51 like autophagy activating kinase 2
Omim:OMIM:608650
Id:ENSG00000083290
Hgnc:HGNC:13480
Entrez:9706
Description:unc-51 like autophagy activating kinase 2
This gene encodes a protein that is similar to a serine/threonine kinase in C. elegans which is involved in axonal elongation. The structure of this protein is similar to the C. elegans protein in that both proteins have an N-terminal kinase domain, a central proline/serine rich (PS) domain, and a C-terminal (C) domain. The gene is located within the Smith-Magenis syndrome region on chromosome 17. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Dec 2008]

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View ULK2's neighborhood in the knowledge graph.

Playbook Workflow Builder
Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with ULK2.

Gene Partnership Appyter
CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using ULK2.

Gene and Drug Landing Page Aggregator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for ULK2.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with ULK2.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.